SEC Form 4/A · accession 0001179110-15-008718
Innoviva, Inc. · INVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
William H Waltrip
Director
Period of report
Apr 24, 2015
Accepted (ET)
May 29, 2015 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080014
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 24, 2015 | A | 13,950 | $0.00 | A | 123,604 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
- F2The initial Form 4 filed on April 27, 2015 by the Reporting Person inadvertently omitted 6,340 shares of common stock subject to RSUs that the reporting person received as a result of an antidilution adjustment pursuant to the Theravance, Inc. 2012 Equity Incentive Plan as a result of the Issuer's spin-off of Theravance Biopharma, Inc.